NCT00420706终止1 期
A Multi-Dose, Double-Blind, Parallel-Group Study of the Effects of Dose Titration and Administration With Food on the Tolerability of SCA-136 in Healthy Subjects
Wyeth is now a wholly owned subsidiary of Pfizer1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2006年12月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 终止
- 发起方
- 入组人数
- 120
- 试验地点
- 1
- 主要终点
- The primary endpoint is the proportion of subjects reporting nausea (based on AEs) over the dosing period.
研究概览
简要总结
To evaluate whether the tolerability of SCA-136 is improved by dosing with food or by increasing dose amounts in a step-wise fashion.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 50 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Healthy men or women, aged 18 to 50 years
排除标准
- •Abnormal vital signs, ECG, or lab results
结局指标
主要结局
The primary endpoint is the proportion of subjects reporting nausea (based on AEs) over the dosing period.
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
Study to Assess Safety and Effectiveness of Slowly Increasing Dose and Food Effect of KarXT in Participants With SchizophreniaSchizophreniaNCT06572449Karuna Therapeutics, Inc., a Bristol Myers Squibb company173
已完成
1 期
Study Evaluating SKI-606 Administered to Healthy SubjectsHealthyNCT00406406Wyeth is now a wholly owned subsidiary of Pfizer
已完成
1 期
Multiple Rising Oral Dose Study of PG 760564 Administered Twice Daily to Healthy Male/Female Volunteers for 14 DaysHealthyNCT00791388Procter and Gamble45
已完成
1 期
Study to Evaluate Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of ASC42 in Healthy SubjectsHealthyNCT04679129Gannex Pharma Co., Ltd.64
已完成
1 期
An Ascending Dose, Single/Multiple Dosing, Food Effect Clinical Trial to Evaluate Pharmacokinetics, Safety and Tolerability in Healthy Subjects After Oral Administration of Gemigliptin (Phase I)Type 2 Diabetes MellitusNCT03864432LG Chem48